FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to psychology and psychophysiology, and can be used to model acute emotional immobilization stress in experiment. That is ensured by immobilizing an animal. Then adrenalin 25 mcg/kg is injected intraperitoneally twice every 3 hours with the duration of immobilization after the first adrenaline introduction for 6 hours.
EFFECT: method provides pathogenetically and psychophysiologically based modeling of emotional immobilization stress in experiment by increasing the emotional response to the background of immobilization of the experimental animal.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SIMULATING CHRONIC EMOTIONAL AND INFORMATION STRESS IN EXPERIMENT | 2018 |
|
RU2697655C1 |
| METHOD FOR SIMULATING ACUTE EMOTIONAL IMMOBILIZATION STRESS DURING PREGNANCY IN EXPERIMENT | 2021 |
|
RU2767919C1 |
| METHOD FOR STUDYING DEVELOPMENT OF INSULIN RESISTANCE IN ACUTE EMOTIONAL-IMMOBILIZATION STRESS IN EXPERIMENT | 2021 |
|
RU2755932C1 |
| 9-[2-(4-ISOPROPYLPHENOXY)ETHYL]ADENINE POSSESSING ANTIDEPRESSANT AND STRESS-RELIEVING ACTION | 2013 |
|
RU2529817C1 |
| METHOD FOR MODELING DEPERSONALIZATION DISORDER | 2005 |
|
RU2311691C2 |
| METHOD FOR EXPERIMENTAL SIMULATION OF STRESS-INDUCED DEVELOPMENT OF ACUTE ULCER BLEEDING | 2011 |
|
RU2472231C1 |
| USE OF N,N"-SUBSTITUTED 3,7-DIAZABICYCLO[3_3_1]NONANES DERIVATIVES FOR DEPRESSION THERAPY | 2019 |
|
RU2726313C1 |
| PHENYLHYDRAZIDE (4-PHENYL-2-PYRROLIDON-1-YL)-ACETIC ACID, HAVING NOOTROPIC, ANTIDEPRESSANT AND ANXIOLYTIC ACTIVITY | 2010 |
|
RU2440981C1 |
| ADAPTOGEN STRESS-CORRECTOR | 2000 |
|
RU2166952C1 |
| SOLUTION THAT INCREASES THE RESISTANCE OF THE HEART TO STRESS DAMAGE | 2021 |
|
RU2775779C1 |
